Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR2 | P41587 | 6/20 | 0.56 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.56 |
| ▸ | F2 | P00734 | 2/20 | 0.54 |
| ▸ | NPY4R | P50391 | 8/20 | 0.53 |
| ▸ | NPY1R | P25929 | 5/20 | 0.53 |
| ▸ | NPY2R | P49146 | 4/20 | 0.53 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.53 |
| ▸ | TFPI | P10646 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29512422 | 0.92 | NPY4R (0.61) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| SCHEMBL31031618 | 0.91 | NPY4R (0.59) | VIPR2NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31277042 | 0.90 | VIPR2 (0.66) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| SCHEMBL30261907 | 0.90 | NPY4R (0.58) | VIPR2VIPR1F2NPY4RNPY1R | |
| Thymopentin SCHEMBL7498758 | 0.90 | NPY4R (0.62) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| Thymopentin SCHEMBL44001 | 0.90 | NPY4R (0.62) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| SCHEMBL8813021 | 0.90 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL8815384 | 0.90 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| Thymopentin SCHEMBL989519 | 0.90 | NPY4R (0.62) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| Thymopentin SCHEMBL29512397 | 0.90 | NPY4R (0.62) | VIPR2VIPR1NPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114316042-A | cTnI protein antigenic determinant polypeptide and application thereof | 天津奇云诺德生物医学有限公司 | 2022-04-12 | — | — | CN | disclosed |